Condition: Leukemia,Myeloid, Chronic · Sponsor: University Hospital, Clermont-Ferrand
French prospective multicenter, open-label study involving newly diagnosed CML patients. Two assessments will be performed during the follow-up of these patients: individual frailty using geriatric tools and individual biological aging determined by DNA methylation analysis.
This description comes directly from the study's public registry record.
Lise LACLAUTRE · +33473754963 · promo_interne_drci@chu-clermontferrand.fr
Mélanie CASILE, PhD · +33473750682 · mcasile@chu-clermontferrand.fr
Always discuss trial participation with your own doctor first.
| CHU Annecy-Genevois | Annecy, France | Recruiting |
| Institut Bergonié | Bordeaux, France | Not Yet Recruiting |
| CHU Caen | Caen, France | Recruiting |
| CHU de Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Créteil | Créteil, France | Not Yet Recruiting |
| CHU Grenoble Alpes | Grenoble, France | Not Yet Recruiting |
| Centre Hospitalier Emile Roux | Le Puy-en-Velay, France | Recruiting |
| CHRU Lille | Lille, France | Not Yet Recruiting |
| CHU Limoges | Limoges, France | Recruiting |
| Centre Léon Bérard | Lyon, France | Withdrawn |
| Institut Paoli-Calmettes | Marseille, France | Recruiting |
| CHU Nancy | Nancy, France | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06130787